Beyond Air, Inc. (XAIR) DCF Valuation

Beyond Air, Inc. (Xair) Valoración de DCF

US | Healthcare | Medical - Devices | NASDAQ
Beyond Air, Inc. (XAIR) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Beyond Air, Inc. (XAIR) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Explore el potencial financiero de Beyond Air, Inc. (XAIR) con nuestra calculadora DCF fácil de usar! Ingrese sus proyecciones para el crecimiento, los márgenes y los gastos para calcular el valor intrínseco de Beyond Air, Inc. (XAIR) e informar su enfoque de inversión.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020		 AY2
2021		 AY3
2022		 AY4
2023		 AY5
2024		 FY1
2025		 FY2
2026		 FY3
2027		 FY4
2028		 FY5
2029
Revenue 1.4 .9 .0 .0 1.2 .8 .5 .3 .2 .1
Revenue Growth, % 0 -37.2 -100 0 0 -34.3 -34.3 -34.3 -34.3 -34.3
EBITDA -19.8 -22.0 -42.7 -58.2 -59.0 -.2 -.1 -.1 .0 .0
EBITDA, % -1427.52 -2522.57 100 100 -5093.27 -20 -20 -20 -20 -20
Depreciation .2 .2 .6 1.2 2.4 .5 .3 .2 .1 .1
Depreciation, % 15.99 28.56 100 100 202.93 68.91 68.91 68.91 68.91 68.91
EBIT -20.1 -22.3 -43.3 -59.4 -61.4 -.2 -.1 -.1 .0 .0
EBIT, % -1443.51 -2551.13 100 100 -5296.2 -20 -20 -20 -20 -20
Total Cash 19.8 34.6 80.2 45.9 34.5 .8 .5 .3 .2 .1
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .6 .7 .5
Account Receivables, % 0 0 100 100 47.28
Inventories 6.5 1.9 .4 1.1 2.1 .8 .5 .3 .2 .1
Inventories, % 469.73 215.35 100 100 183.52 100 100 100 100 100
Accounts Payable 2.3 1.3 1.1 2.0 1.9 .8 .5 .3 .2 .1
Accounts Payable, % 162.31 151.78 100 100 168.08 100 100 100 100 100
Capital Expenditure .0 -.9 -1.4 -3.9 -5.7 -.3 -.2 -.1 -.1 -.1
Capital Expenditure, % -3.14 -101.95 100 100 -495.69 -40.63 -40.63 -40.63 -40.63 -40.63
Tax Rate, % 6.3 6.3 6.3 6.3 6.3 6.3 6.3 6.3 6.3 6.3
EBITAT -19.9 -22.3 -42.4 -55.8 -57.5 -.1 -.1 -.1 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -24.0 -19.2 -42.5 -58.4 -61.9 .4 .2 .1 .1 .0
WACC, % 11.34 11.41 11.23 10.87 10.84 11.14 11.14 11.14 11.14 11.14
PV UFCF
SUM PV UFCF .7
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 1
Present Terminal Value 0
Enterprise Value 1
Net Debt 6
Equity Value -5
Diluted Shares Outstanding, MM 33
Equity Value Per Share -0.16

What You Will Get

  • Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to explore various scenarios.
  • Real-World Data: Beyond Air, Inc. (XAIR) financial data pre-filled to accelerate your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
  • Customizable and Professional: A sleek Excel model that adjusts to your valuation requirements.
  • Built for Analysts and Investors: Perfect for testing projections, validating strategies, and enhancing efficiency.

Key Features

  • Accurate Financial Data: Gain access to reliable pre-loaded historical figures and future forecasts for Beyond Air, Inc. (XAIR).
  • Adjustable Forecast Parameters: Modify highlighted cells for key metrics such as WACC, growth rates, and profit margins.
  • Real-Time Calculations: Instant updates to DCF, Net Present Value (NPV), and cash flow analyses.
  • User-Friendly Dashboard: Clear and concise charts and summaries to help you visualize valuation outcomes.
  • Designed for All Users: A straightforward, intuitive layout tailored for investors, CFOs, and consultants alike.

How It Works

  • Step 1: Download the prebuilt Excel template featuring Beyond Air, Inc. (XAIR) data.
  • Step 2: Navigate through the pre-filled sheets to familiarize yourself with the essential metrics.
  • Step 3: Adjust forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly see the recalculated results, including the intrinsic value of Beyond Air, Inc. (XAIR).
  • Step 5: Make well-informed investment decisions or create reports based on the results.

Why Choose Beyond Air, Inc. (XAIR)?

  • Innovative Solutions: Leverage cutting-edge technologies for enhanced respiratory care.
  • Proven Results: Our products have demonstrated significant clinical benefits in real-world settings.
  • Patient-Centric Approach: Focused on improving patient outcomes and quality of life.
  • Expert Support: Our team of professionals is dedicated to providing exceptional service and guidance.
  • Industry Recognition: A trusted name in the healthcare sector, backed by numerous accolades.

Who Should Use Beyond Air, Inc. (XAIR)?

  • Healthcare Professionals: Explore innovative treatment options and their financial implications.
  • Researchers: Integrate advanced models into studies focused on respiratory therapies.
  • Investors: Evaluate your investment strategies and assess the market potential of Beyond Air, Inc. (XAIR).
  • Analysts: Enhance your analysis with a customizable financial model tailored for biotech firms.
  • Entrepreneurs: Understand how public companies like Beyond Air, Inc. (XAIR) navigate the healthcare landscape.

What the Template Contains

  • Pre-Filled Data: Includes Beyond Air, Inc.’s historical financials and forecasts.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
  • Key Financial Ratios: Analyze Beyond Air, Inc.'s profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
  • Clear Dashboard: Charts and tables summarizing key valuation results.

No products were found matching.